Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-20 Sale |
2025-02-24 4:19 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO |
3,894 | $4.25 | $16,550 | 312,147 (Direct) |
View |
2025-02-11 Sale |
2025-02-12 4:21 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO |
6,950 | $4.45 | $30,928 | 102,291 (Direct) |
View |
2025-01-14 Sale |
2025-01-15 4:18 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO |
3,087 | $5.09 | $15,713 | 109,241 (Direct) |
View |
2024-12-23 Sale |
2024-12-26 4:29 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO&CBO |
6,500 | $5.65 | $36,725 | 112,328 (Direct) |
View |
2024-04-02 Sale |
2024-04-03 4:13 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
1,357 | $9.88 | $13,407 | 117,004 (Direct) |
View |
2024-02-21 Sale |
2024-02-22 4:36 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
3,966 | $7.45 | $29,547 | 118,361 (Direct) |
View |
2024-01-17 Sale |
2024-01-19 4:34 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
2,543 | $7.15 | $18,182 | 72,327 (Direct) |
View |
2023-04-03 Sale |
2023-04-05 5:02 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
1,259 | $7.83 | $9,858 | 71,617 (Direct) |
View |
2023-03-20 Sale |
2023-03-22 4:48 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
3,654 | $7.76 | $28,355 | 72,876 (Direct) |
View |
2023-03-15 Sale |
2023-03-17 4:37 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
15,373 | $8.2 | $126,059 | 76,530 (Direct) |
View |
2023-01-17 Sale |
2023-01-19 4:53 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
2,188 | $9.8487 | $21,549 | 51,903 (Direct) |
View |
2022-04-04 Sale |
2022-04-06 4:34 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
1,527 | $8.25 | $12,598 | 52,060 (Direct) |
View |
2022-03-21 Sale |
2022-03-23 6:40 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
4,413 | $8.2945 | $36,604 | 53,587 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-21 Option Award |
2025-02-24 4:19 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Swartz Robin COO & CBO |
213,750 | $0 | 312,147 (Direct) |
View |
2024-02-09 Option Award |
2024-02-16 5:03 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
150,000 | $0 | 222,327 (Direct) |
View |
2023-02-17 Option Award |
2023-02-22 8:52 pm |
N/A 2033-02-17 |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
120,000 | $0 | 171,903 (Direct) |
View |
2022-02-07 Option Award |
2022-02-09 4:28 pm |
N/A 2032-02-07 |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
65,000 | $0 | 65,000 (Direct) |
View |
Ownership |
2022-02-09 4:26 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
0 | $0 | 254,500 (Direct) |
View |